Editas Medicine, Inc.
EDIT- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001650664
In the last 90 days, Editas Medicine, Inc. insiders filed 0 open-market purchases and 5 sales; 215 institutions reported holding it in 13F filings for Q2 2026, worth $386.3M in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in Editas Medicine, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 236
- +12 vs. Q1 2024
- Shares held
- 56.4M
- −10.6M (−15.8%) vs. Q1 2024
- Total value
- $263.3M
- −$233.3M (−47.0%) vs. Q1 2024
- New holders
- 49
- 65 more added
- Sold out
- 37
- 72 more reduced
2 institutions that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EDIT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 215 | $386.3M |
| Q1 2026 | 208 | $127.5M |
| Q4 2025 | 197 | $102.5M |
| Q3 2025 | 194 | $149.3M |
| Q2 2025 | 194 | $90.9M |
| Q1 2025 | 195 | $51.0M |
| Q4 2024 | 207 | $64.8M |
| Q3 2024 | 230 | $187.7M |
| Q2 2024 | 236 | $263.3M |
| Q1 2024 | 226 | $503.8M |
| Q4 2023 | 226 | $595.7M |
| Q3 2023 | 222 | $481.0M |
| Q2 2023 | 238 | $516.8M |
| Q1 2023 | 236 | $384.0M |
| Q4 2022 | 251 | $479.3M |
| Q3 2022 | 265 | $590.5M |
| Q2 2022 | 258 | $561.5M |
| Q1 2022 | 257 | $862.3M |
| Q4 2021 | 307 | $1.36B |
| Q3 2021 | 321 | $2.17B |
| Q2 2021 | 316 | $2.96B |
| Q1 2021 | 314 | $2.23B |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Editas Medicine, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Jacobs Levy Equity Management, Inc | 227,182 | $1.06M | 0.00% | +108,042+90.7% | Added |
| PDT Partners, LLC | 246,537 | $1.15M | 0.11% | +196,041+388.2% | Added |
| Nuveen Asset Management, LLC | 256,031 | $1.20M | 0.00% | −767,149−75.0% | Reduced |
| ExodusPoint Capital Management, LP | 261,381 | $1.22M | 0.01% | +261,381 | New |
| State of Michigan Retirement System | 273,721 | $1.28M | 0.01% | 00.0% | Unchanged |
| Jane Street Group, LLC | 290,136 | $1.35M | 0.00% | +125,262+76.0% | Added |
| Bank of New York Mellon Corp | 296,154 | $1.38M | 0.00% | +11,332+4.0% | Added |
| HRT Financial LP | 298,030 | $1.39M | 0.01% | +298,030 | New |
| Susquehanna International Group, LLP | 313,197 | $1.46M | 0.00% | +102,849+48.9% | Added |
| UBS Group AG | 342,121 | $1.60M | 0.00% | −253,844−42.6% | Reduced |
| Marshall Wace, LLP | 449,153 | $2.10M | 0.00% | −342,167−43.2% | Reduced |
| Stifel Financial Corp | 453,220 | $2.12M | 0.00% | +219,517+93.9% | Added |
| Trexquant Investment LP | 472,715 | $2.21M | 0.03% | +273,510+137.3% | Added |
| Raymond James & Associates | 526,815 | $2.46M | 0.00% | +174,993+49.7% | Added |
| Bank of America Corp | 539,726 | $2.52M | 0.00% | −356,921−39.8% | Reduced |
| Two Sigma Investments, LP | 540,588 | $2.52M | 0.01% | −847,394−61.1% | Reduced |
| D. E. Shaw & Co., Inc. | 550,853 | $2.57M | 0.00% | −538,387−49.4% | Reduced |
| Integral Health Asset Management, LLC | 675,000 | $3.15M | 0.31% | +225,000+50.0% | Added |
| Squarepoint Ops LLC | 694,180 | $3.24M | 0.01% | −204,276−22.7% | Reduced |
| Charles Schwab Investment Management Inc | 733,385 | $3.42M | 0.00% | −122,710−14.3% | Reduced |
| Northern Trust Corp | 737,345 | $3.44M | 0.00% | −95,535−11.5% | Reduced |
| JPMorgan Chase & Co | 799,198 | $3.73M | 0.00% | −182,323−18.6% | Reduced |
| Avidity Partners Management LP | 816,000 | $3.81M | 0.16% | +816,000 | New |
| Two Sigma Advisers, LP | 856,500 | $4.00M | 0.01% | −377,800−30.6% | Reduced |
| UBS Asset Management Americas Inc | 901,623 | $4.21M | 0.00% | +818,056+978.9% | Added |
| Morgan Stanley | 918,234 | $4.29M | 0.00% | −865,498−48.5% | Reduced |
| Woodline Partners LP | 970,491 | $4.53M | 0.04% | +75,491+8.4% | Added |
| Goldman Sachs Group Inc | 1,218,687 | $5.69M | 0.00% | −182,245−13.0% | Reduced |
| Pictet Asset Management Holding SA | 1,427,277 | $6.67M | 0.01% | −834,368−36.9% | Reduced |
| Geode Capital Management, LLC | 1,965,822 | $9.18M | 0.00% | +21,059+1.1% | Added |
| Dimensional Fund Advisors LP | 2,345,054 | $11.0M | 0.00% | −262,711−10.1% | Reduced |
| Millennium Management LLC | 2,459,629 | $11.5M | 0.01% | +223,012+10.0% | Added |
| State Street Corp | 4,590,913 | $21.4M | 0.00% | −4,169,238−47.6% | Reduced |
| Deep Track Capital, LP | 6,000,000 | $28.0M | 0.84% | +472,710+8.6% | Added |
| BlackRock Inc. | 7,782,517 | $36.3M | 0.00% | −50,264−0.6% | Reduced |
| Vanguard Group Inc | 8,032,604 | $37.5M | 0.00% | −522,993−6.1% | Reduced |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −1,045,255−100.0% | Sold out |
| Neuberger Berman Group LLC | 0 | $0 | 0.00% | −275,069−100.0% | Sold out |
| Graham Capital Management, L.P. | 0 | $0 | 0.00% | −62,106−100.0% | Sold out |
| Algert Global LLC | 0 | $0 | 0.00% | −54,510−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −45,155−100.0% | Sold out |
| Patriot Financial Group Insurance Agency, LLC | 0 | $0 | 0.00% | −43,863−100.0% | Sold out |
| Voloridge Investment Management, LLC | 0 | $0 | 0.00% | −41,414−100.0% | Sold out |
| American International Group, Inc. | 0 | $0 | 0.00% | −40,540−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −40,461−100.0% | Sold out |
| UBS Oconnor LLC | 0 | $0 | 0.00% | −37,403−100.0% | Sold out |
| Sherbrooke Park Advisers LLC | 0 | $0 | 0.00% | −36,858−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −31,321−100.0% | Sold out |
| Bayesian Capital Management, LP | 0 | $0 | 0.00% | −24,400−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −21,698−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −19,261−100.0% | Sold out |
| Quest Partners LLC | 0 | $0 | 0.00% | −17,458−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −16,500−100.0% | Sold out |
| Mariner, LLC | 0 | $0 | 0.00% | −16,389−100.0% | Sold out |
| Corton Capital Inc. | 0 | $0 | 0.00% | −15,832−100.0% | Sold out |
| Keystone Financial Group | 0 | $0 | 0.00% | −14,000−100.0% | Sold out |
| Ci Investments Inc. | 0 | $0 | 0.00% | −11,222−100.0% | Sold out |
| HB Wealth Management, LLC | 0 | $0 | 0.00% | −10,198−100.0% | Sold out |
| Independent Advisor Alliance | 0 | $0 | 0.00% | −10,110−100.0% | Sold out |
| EntryPoint Capital, LLC | 0 | $0 | 0.00% | −9,669−100.0% | Sold out |
| Headlands Technologies LLC | 0 | $0 | 0.00% | −9,493−100.0% | Sold out |
| Metropolitan Life Insurance Co | 0 | $0 | 0.00% | −3,989−100.0% | Sold out |
| Crewe Advisors LLC | 0 | $0 | 0.00% | −1,900−100.0% | Sold out |
| Fernwood Investment Management, LLC | 0 | $0 | 0.00% | −726−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −400−100.0% | Sold out |
| America First Investment Advisors, LLC | 0 | $0 | 0.00% | −150−100.0% | Sold out |
| Spire Wealth Management | 0 | $0 | 0.00% | −150−100.0% | Sold out |
| Truvestments Capital LLC | 0 | $0 | 0.00% | −61−100.0% | Sold out |
| First Manhattan Co | 0 | $0 | 0.00% | −43−100.0% | Sold out |
| Creative Financial Designs Inc | 0 | $0 | 0.00% | −40−100.0% | Sold out |
| NewSquare Capital LLC | 0 | $0 | 0.00% | −30−100.0% | Sold out |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 0 | $0 | 0.00% | −17−100.0% | Sold out |
| Sittner & Nelson, LLC | 0 | $0 | 0.00% | −6−100.0% | Sold out |
| Credit Suisse AG | – | – | – | – | Not filed |
| Shell Asset Management Co | – | – | – | – | Not filed |